Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | iNeo-Vac-P01 + Sargramostim |
Synonyms | |
Therapy Description | |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Sargramostim | Leukine | GM-CSF|Prokine | ||
iNeo-Vac-P01 | Personalized Neoantigen Peptide Vaccine iNeo-Vac-P01 | iNeo-Vac-P01 is a personalized neoantigen vaccine consisting of patient-specific peptides, which may result in increased immune response, activation of CD4+ and CD8+ T cells, and tumor cell killing (PMID: 32439700). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|